Histopathologic tumor response after induction chemotherapy and stereotactic body radiation therapy for borderline resectable pancreatic cancer.
about
Association of Clinical Factors With a Major Pathologic Response Following Preoperative Therapy for Pancreatic Ductal Adenocarcinoma.Impact of sarcopenia in borderline resectable and locally advanced pancreatic cancer patients receiving stereotactic body radiation therapy.Perioperative and Survival Outcomes Following Neoadjuvant FOLFIRINOX versus Gemcitabine Abraxane in Patients with Pancreatic Adenocarcinoma.
P2860
Histopathologic tumor response after induction chemotherapy and stereotactic body radiation therapy for borderline resectable pancreatic cancer.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Histopathologic tumor response ...... resectable pancreatic cancer.
@ast
Histopathologic tumor response ...... resectable pancreatic cancer.
@en
type
label
Histopathologic tumor response ...... resectable pancreatic cancer.
@ast
Histopathologic tumor response ...... resectable pancreatic cancer.
@en
prefLabel
Histopathologic tumor response ...... resectable pancreatic cancer.
@ast
Histopathologic tumor response ...... resectable pancreatic cancer.
@en
P2093
P2860
P1476
Histopathologic tumor response ...... resectable pancreatic cancer.
@en
P2093
Barbara A Centeno
Eric A Mellon
Gregory M Springett
Jessica M Frakes
Michael D Chuong
Mokenge P Malafa
Nicholas Figura
Pamela J Hodul
Ravi Shridhar
Sarah E Hoffe
P2860
P304
P356
10.3978/J.ISSN.2078-6891.2015.075
P577
2016-04-01T00:00:00Z